Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"No surprises" in first half for AOI after R&D (research and development) widens net loss

This article was originally published in Clinica

Executive Summary

Orlando, Florida-based orthopaedics specialist AOI Medical has stated that "everything is according to plan", despite seeing its net loss widen to $1.8m for the six months ending June 30 2007. The firm doubled its net loss to reflect its rising operating expenses - a result of a five-fold increase in R&D spending to $577,000, and administrative costs nearly doubling to $1m. During this period, the company also invested in expanding its workforce, and sales and marketing activities.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel